This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Purpose
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions. The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.
Condition
- Atopic Dermatitis
Eligibility
- Eligible Ages
- Over 12 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Patients aged more than or equal to (≥) 12 years at the time of consent. - Confirmed diagnosis of AD, of any severity, according to the Investigator's assessment as aligned with International Classification of Diseases 10th revision (ICD-10) code of L20. - Prescribed and scheduled to initiate any systemic treatment for AD (including but not limited to biologics, oral Janus kinase (JAK) inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil) - Signed informed consent for registry participation by the patient or parent/legal representative and assent by the patient appropriate to the patient's age, including willingness to participate in long-term follow-up.
Exclusion Criteria
- Concurrent participation in an interventional clinical trial that administers an investigational drug that modifies patient care. - Insufficient understanding of the study by the patient and/or parent/guardian. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Atopic Dermatitis | This study plans to collect information on adolescent and adult patients with atopic dermatitis who initiate or switch any systemic treatment (eg, biologics, oral Janus kinase [JAK] inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil) for AD according to the country-specific prescribing information. During the study, investigators will prescribe medical products for treatment of AD per standard of care (SoC) and per medical judgment. |
Recruiting Locations
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Birmingham, Alabama 35244
Birmingham, Alabama 35244
River Region Dermatology and Laser- Site Number : 8400041
Montgomery, Alabama 36117
Montgomery, Alabama 36117
San Tan Allergy & Asthma- Site Number : 8400031
Gilbert, Arizona 85234
Gilbert, Arizona 85234
Kern Research, Inc.- Site Number : 8400047
Bakersfield, California 93301
Bakersfield, California 93301
Center for Dermatology Clinical Research- Site Number : 8400014
Fremont, California 94538
Fremont, California 94538
Dermatology Research Associates - Los Angeles- Site Number : 8400020
Los Angeles, California 90045
Los Angeles, California 90045
Northridge Clinical Trials, LLC- Site Number : 8400009
Northridge, California 91325
Northridge, California 91325
Sunwise Clinical Research, LLC.- Site Number : 8400010
Oakland, California 94596
Oakland, California 94596
Empire Clinical Research, LLC- Site Number : 8400007
Pomona, California 91767
Pomona, California 91767
University Clinical Trials- Site Number : 8400019
San Diego, California 92123
San Diego, California 92123
Western States Clinical Research, Inc.- Site Number : 8400051
Wheat Ridge, Colorado 80033
Wheat Ridge, Colorado 80033
St. Jude Clinical Research- Site Number : 8400049
Doral, Florida 33172
Doral, Florida 33172
Ziaderm Research, LLC- Site Number : 8400021
North Miami Beach, Florida 33162-4708
North Miami Beach, Florida 33162-4708
Skin Care Physicians of Georgia - Macon- Site Number : 8400034
Macon, Georgia 31217
Macon, Georgia 31217
Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029
Normal, Illinois 61761
Normal, Illinois 61761
Rosalind Franklin University of Medicine and Science- Site Number: 8400056
North Chicago, Illinois 60064
North Chicago, Illinois 60064
David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017
Ann Arbor, Michigan 48103
Ann Arbor, Michigan 48103
Oakland Hills Dermatology- Site Number : 8400042
Auburn Hills, Michigan 48326
Auburn Hills, Michigan 48326
Great Lakes Research Group - Bay City- Site Number : 8400052
Bay City, Michigan 48706
Bay City, Michigan 48706
The Derm Institute of West Michigan- Site Number : 8400025
Caledonia, Michigan 49316
Caledonia, Michigan 49316
Michigan Dermatology Institute - Waterford- Site Number : 8400013
Waterford, Michigan 48328
Waterford, Michigan 48328
Red River Research Partners, Llc- Site Number : 8400054
Bolivar, Missouri 65613
Bolivar, Missouri 65613
Cleaver Dermatology- Site Number : 8400033
Kirksville, Missouri 63501
Kirksville, Missouri 63501
Allergy Asthma & Immunology- Site Number : 8400044
Lincoln, Nebraska 68510
Lincoln, Nebraska 68510
Las Vegas Dermatology- Site Number : 8400002
Las Vegas, Nevada 89144
Las Vegas, Nevada 89144
Optima Research Portsmouth- Site Number : 8400032
Portsmouth, New Hampshire 03801
Portsmouth, New Hampshire 03801
University Of New Mexico School Of Medicine- Site Number : 8400022
Albuquerque, New Mexico 87102
Albuquerque, New Mexico 87102
Piedmont Plastic Surgery and Dermatology- Site Number : 8400038
Huntersville, North Carolina 28078
Huntersville, North Carolina 28078
Wake Forest University Health Sciences- Site Number : 8400003
Winston-Salem, North Carolina 27104
Winston-Salem, North Carolina 27104
Red River Research Partners - Fargo- Site Number : 8400037
Fargo, North Dakota 58103
Fargo, North Dakota 58103
Dermatologists of Southwest Ohio - Mason- Site Number : 8400050
Mason, Ohio 45040
Mason, Ohio 45040
UPMC - Department of Dermatology- Site Number : 8400024
Pittsburgh, Pennsylvania 15213
Pittsburgh, Pennsylvania 15213
Care Access Research - Warwick 2- Site Number : 8400045
Warwick, Rhode Island 02886
Warwick, Rhode Island 02886
Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004
Spartanburg, South Carolina 29307
Spartanburg, South Carolina 29307
Reveal Research Institute - Dallas- Site Number : 8400012
Dallas, Texas 75235
Dallas, Texas 75235
Innovate Research - Fort Worth- Site Number : 8400016
Fort Worth, Texas 76244
Fort Worth, Texas 76244
Austin Institute for Clinical Research, Inc- Site Number : 8400030
Pflugerville, Texas 78660
Pflugerville, Texas 78660
Complete Dermatology - Sugar Land- Site Number : 8400001
Sugar Land, Texas 77479
Sugar Land, Texas 77479
Cope Family Medicine-Site Number : 8400053
Bountiful, Utah 84010-8917
Bountiful, Utah 84010-8917
Springville Dermatology - Springville- Site Number : 8400055
Springville, Utah 84663
Springville, Utah 84663
Fuchs Dermatology- Site Number : 8400027
Falls Church, Virginia 22042
Falls Church, Virginia 22042
Frontier Dermatology Partners CRO LLC- Site Number : 8400011
Mill Creek, Washington 98012
Mill Creek, Washington 98012
University of Washington - Roosevelt Location- Site Number : 8400005
Seattle, Washington 98105
Seattle, Washington 98105
More Details
- Status
- Recruiting
- Sponsor
- Sanofi
Study Contact
Trial Transparency email recommended (Toll free for US & Canada)800-633-1610
Contact-US@sanofi.com